0001140361-22-023046.txt : 20220615 0001140361-22-023046.hdr.sgml : 20220615 20220615160054 ACCESSION NUMBER: 0001140361-22-023046 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220610 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20220615 DATE AS OF CHANGE: 20220615 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kinnate Biopharma Inc. CENTRAL INDEX KEY: 0001797768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824566526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39743 FILM NUMBER: 221017755 BUSINESS ADDRESS: STREET 1: 11975 EL CAMINO REAL, STE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8582994699 MAIL ADDRESS: STREET 1: 11975 EL CAMINO REAL, STE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 8-K 1 brhc10038769_8k.htm 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)
June 10, 2022


KINNATE BIOPHARMA INC.
(Exact name of registrant as specified in its charter)



Delaware
001-39743
82-4566526
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

103 Montgomery Street, Suite 150
The Presidio of San Francisco
San Francisco, CA 94129
(Address, including zip code, of Registrant’s principal executive offices)

(858) 299-4699
(Registrant’s telephone number, including area code)

N/A
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading
Symbol(s)

Name of each exchange on which registered
Common Stock, par value $0.0001 per share

KNTE

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.07
Submission of Matters to a Vote of Security Holders.

Kinnate Biopharma Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”) on June 10, 2022.  The proposals voted upon at the Annual Meeting and the voting results for each proposal are set forth below.

Proposal 1: Election of Three Class II Directors


Name of Director Nominee

For

Withheld

Broker Non-Votes

 
 
 
 

Laurie Smaldone Alsup, Ph.D.

27,453,597

4,981,263

3,924,331

 
 
 
 

Melissa Epperly

27,552,424

4,882,436

3,924,331

 
 
 
 

Michael Rome

24,665,425

7,769,435

3,924,331

 
     
 

Each director nominee was duly elected to serve until the 2025 annual meeting of stockholders and until their successor is duly elected and qualified, subject to earlier resignation or removal.

Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm

 
For
 
Against
 
Abstain
 
Broker Non-Votes
               
 
36,332,123
 
26,557
 
511
 
0
               

The stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
KINNATE BIOPHARMA INC.
   
Date: June 15, 2022
By:
/s/ Nima Farzan
 
Nima Farzan
 
Chief Executive Officer and President



EX-101.SCH 2 knte-20220610.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 knte-20220610_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Ex Transition Period Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 4 knte-20220610_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information
Jun. 10, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 10, 2022
Entity Registrant Name KINNATE BIOPHARMA INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-39743
Entity Tax Identification Number 82-4566526
Entity Address, Address Line One 103 Montgomery Street
Entity Address, Address Line Two Suite 150
Entity Address, City or Town San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94129
City Area Code 858
Local Phone Number 299-4699
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001797768
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol KNTE
Security Exchange Name NASDAQ
XML 6 brhc10038769_8k_htm.xml IDEA: XBRL DOCUMENT 0001797768 2022-06-10 2022-06-10 false CA 0001797768 8-K 2022-06-10 KINNATE BIOPHARMA INC. DE 001-39743 82-4566526 103 Montgomery Street Suite 150 San Francisco 94129 858 299-4699 false false false false Common Stock, par value $0.0001 per share KNTE NASDAQ true false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 24 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://kinnate.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports brhc10038769_8k.htm knte-20220610.xsd knte-20220610_lab.xml knte-20220610_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "brhc10038769_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "brhc10038769_8k.htm" ] }, "labelLink": { "local": [ "knte-20220610_lab.xml" ] }, "presentationLink": { "local": [ "knte-20220610_pre.xml" ] }, "schema": { "local": [ "knte-20220610.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 30, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "knte", "nsuri": "http://kinnate.com/20220610", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10038769_8k.htm", "contextRef": "c20220610to20220610", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://kinnate.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10038769_8k.htm", "contextRef": "c20220610to20220610", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 14 0001140361-22-023046-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-22-023046-xbrl.zip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end